Induction of alkaline phosphatase activity by l-ascorbic acid in human osteoblastic cells: a potential role for CK2 and Ikaros

Nutrition

Volumn 23, Issue 10, 2007, Pages 745-753

  Son, Eunwha ^a   Do, Hang ^b   Joo, Hae Mi ^b   Pyo, Suhkneung ^b  

^a Kangwon National University   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

Alkaline phosphatase; casein kinase 2; Ikaros; l ascorbic acid; Osteoblastogenesis

Indexed keywords

5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; ALKALINE PHOSPHATASE; ASCORBIC ACID; CASEIN KINASE II; COLLAGEN; DNA; IKAROS TRANSCRIPTION FACTOR; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PHOSPHOTRANSFERASE INHIBITOR; SMALL INTERFERING RNA;

ARTICLE; BINDING AFFINITY; BIOCHEMISTRY; CELL DIFFERENTIATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ALKALINE PHOSPHATASE; ASCORBIC ACID; CASEIN KINASE II; CELL DIFFERENTIATION; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; IKAROS TRANSCRIPTION FACTOR; NF-KAPPA B; OSTEOBLASTS; OSTEOPROTEGERIN; RANK LIGAND; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 34548645749     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2007.06.013     Document Type: Article

References (40)

1. Karsenty G. The complexities of skeletal biology. Nature 423 (2003) 316-318
2. Mohan S., Kutilek S., Zhang C., Shen H.G., Kodama Y., Srivastava A.K., et al. Comparison of bone formation responses to parathyroid hormone(1-34), (1-31), and (2-34) in mice. Bone 27 (2000) 471-478
3. Aubin J.E., and Triffitt J.T. Mesenchymal stem cells and osteoblast differentiation. In: Bilezikian J.P., Raisz L.G., and Rodan G.A. (Eds). Principles of bone biology. 2nd ed. (2002), Academic Press, San Diego 59-81
4. Udagawa N., Takahashi N., Yasuda H., Mizuno A., Itoh K., Ueno Y., et al. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology 141 (2000) 3478-3484
5. Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology 142 (2001) 5050-5055
6. Kostenuik P.J., and Shalhoub V. Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption. Curr Pharm Des 7 (2001) 613-635
7. Hamdy N.A. Targeting the RANK/RANKL/OPG signaling pathway: a novel approach in the management of osteoporosis. Curr Opin Investig Drugs 8 (2007) 299-303
8. Prockop D.J., and Kivirikko K.I. Collagens: molecular biology, diseases, and potentials for therapy. Annu Rev Biochem 64 (1995) 403-434
9. Otsuka E., Kato Y., Hirose S., and Hagiwara H. Role of ascorbic acid in the osteoclast formation: induction of osteoclast differentiation factor with formation of the extracellular collagen matrix. Endocrinology 141 (2000) 3006-3011
10. Altaf F.M., Hering T.M., Kazmi N.H., Yoo J.U., and Johnstone B. Ascorbate-enhanced chondrogenesis of ATDC5 cells. Eur Cell Mater 12 (2006) 64-69
11. Kihara T., Hirose M., Oshima A., and Ohgushi H. Exogenous type I collagen facilitates osteogenic differentiation and acts as a substrate for mineralization of rat marrow mesenchymal stem cells in vitro. Biochem Biophys Res Commun 341 (2006) 1029-1035
12. Tsuneto M., Yamazaki H., Yoshino M., Yamada T., and Hayashi S. Ascorbic acid promotes osteoclastogenesis from embryonic stem cells. Biochem Biophys Res Commun 335 (2005) 1239-1246
13. Kathrein K.L., Lorenz R., Innes A.M., Griffiths E., and Winandy S. Ikaros induces quiescence and T-cell differentiation in a leukemia cell line. Mol Cell Biol 25 (2005) 1645-1654
14. Cobb B.S., and Smale S.T. Ikaros-family proteins: in search of molecular functions during lymphocyte development. Curr Top Microbiol Immunol 290 (2005) 29-47
15. Sun P., and Loh H.H. Transcriptional regulation of mouse delta-opioid receptor gene. Role of Ikaros in the stimulated transcription of mouse delta-opioid receptor gene in activated T cells. J Biol Chem 277 (2002) 12854-12860
16. Koipally J., and Georgopoulos K. Ikaros interactions with CtBP reveal a repression mechanism that is independent of histone deacetylase activity. J Biol Chem 275 (2000) 19594-19602
17. Trinh L.A., Ferrini R., Cobb B.S., Weinmann A.S., Hahm K., Ernst P., et al. Down-regulation of TDT transcription in CD4(+)CD8(+) thymocytes by Ikaros proteins in direct competition with an Ets activator. Genes Dev 15 (2001) 1817-1832
18. O'Neill D.W., Schoetz S.S., Lopez R.A., Castle M., Rabinowitz L., Shor E., et al. An Ikaros-containing chromatin-remodeling complex in adult-type erythroid cells. Mol Cell Biol 20 (2000) 7572-7582
19. Yamane K., and Kinsella T.J. Casein kinase 2 regulates both apoptosis and the cell cycle following DNA damage induced by 6-thioguanine. Clin Cancer Res 11 (2005) 2355-2363
20. Panova T.B., Panov K.I., Russell J., and Zomerdijk J.C. Casein kinase 2 associates with initiation-competent RNA polymerase I and has multiple roles in ribosomal DNA transcription. Mol Cell Biol 26 (2006) 5957-5968
21. Canton D.A., and Litchfield D.W. The shape of things to come: an emerging role for protein kinase CK2 in the regulation of cell morphology and the cytoskeleton. Cell Signal 18 (2006) 267-275
22. Litchfield D.W. Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem J 369 pt 1 (2003) 1-15
23. Ahmed K., Gerber D.A., and Cochet C. Joining the cell survival squad: an emerging role for protein kinase CK2. Trends Cell Biol 12 (2002) 226-230
24. Unger G.M., Davis A.T., Slaton J.W., and Ahmed K. Protein kinase CK2 as regulator of cell survival: implications for cancer therapy. Curr Cancer Drug Targets 4 1 (2004) 77-84
25. Wang G., Unger G., Ahmad K.A., Slaton J.W., and Ahmed K. Downregulation of CK2 induces apoptosis in cancer cells-a potential approach to cancer therapy. Mol Cell Biochem 274 (2005) 77-84
26. Olsten M.E., and Litchfield D.W. Order or chaos?. An evaluation of the regulation of protein kinase CK2. Biochem Cell Biol 82 (2004) 681-693
27. Meggio F., and Pinna L.A. On-thousand-and-one substrates of protein kinase CK2?. FASEB J 17 (2003) 349-368
28. Gomez-del Arco P., Maki K., and Georgopoulos K. Phosphorylation controls Ikaros's ability to negatively regulate the G(1)-S transition. Mol Cell Biol 24 (2004) 2797-2807
29. Lorenz P., Pepperkok R., Ansorge W., and Pyerin W. Cell biological studies with monoclonal and polyclonal antibodies against human casein kinase II subunit beta demonstrate participation of the kinase in mitogenic signaling. J Biol Chem 268 (1993) 2733-2739
30. Yamane K., and Kinsella T.J. CK2 inhibits apoptosis and changes its cellular localization following ionizing radiation. Cancer Res 65 (2005) 4362-4367
31. Franceschi R.T., and Young J. Regulation of alkaline phosphatase by 1,25-dihydroxyvitamin D3 and ascorbic acid in bone-derived cells. J Bone Miner Res 5 (1990) 1157-1167
32. Shiga M., Kapila Y.L., Zhang Q., Hayami T., and Kapila S. Ascorbic acid induces collagenase-1 in human periodontal ligament cells but not in MC3T3-E1 osteoblast-like cells: potential association between collagenase expression and changes in alkaline phosphatase phenotype. J Bone Miner Res 18 (2003) 67-77
33. Nohutcu R.M., McCauley L.K., Koh A.J., and Somerman M.J. Expression of extracellular matrix proteins in human periodontal ligament cells during mineralization in vitro. J Periodontol 68 (1997) 320-327
34. Hayami T., Zhang Q., Kapila Y., and Kapila S. Dexamethasone's enhancement of osteoblastic markers in human periodontal ligament cells is associated with inhibition of collagenase expression. Bone 40 (2007) 93-104
35. Glaser J.H., and Conrad H.E. Formation of matrix vesicles by cultured chick embryo chondrocytes. J Biol Chem 256 (1981) 12607-12611
36. Leboy P.S., Vaias L., Uschmann B., Golub E., Adams S.L., and Pacifici M. Ascorbic acid induces alkaline phosphatase, type X collagen, and calcium deposition in cultured chick chondrocytes. J Biol Chem 264 (1989) 17281-17286
37. Takamizawa S., Maehata Y., Imai K., Senoo H., Sato S., and Hata R. Effects of ascorbic acid and ascorbic acid 2-phosphate, a long-acting vitamin C derivative, on the proliferation and differentiation of human osteoblast-like cells. Cell Biol Int 28 (2004) 255-265
38. Wada T., Nakashima T., Hiroshi N., and Penninger J.M. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 12 (2006) 17-25
39. Grimaud E., Soubigou L., Couillaud S., Coipeau P., Moreau A., Passuti N., et al. Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis. Am J Pathol 163 (2003) 2021-2031
40. Xiao X.H., Liao E.Y., Zhou H.D., Dai R.C., Yuan L.Q., and Wu X.P. Ascorbic acid inhibits osteoclastogenesis of RAW 264.7 cells induced by receptor activated nuclear factor kappaB ligand (RANKL) in vitro. J Endocrinol Invest 28 (2005) 253-260